Our History, Your Future
Continued research. Uncompromising innovation.
Steadfast leadership.
For more than 150 years, Pfizer has been changing the course of diseases and lives through the introduction of new treatments and services.
Today, Pfizer Hemophilia is striving to meet the needs of the hemophilia community. We're setting progress into motion, with state-of-the-art manufacturing and purification processes, convenient reconstitution devices, dedicated support, and the conviction and compassion it takes to advance.
Partnerships with promise
Pfizer understands the community's desire for innovation and advancement. We're working with the best scientific minds, technologies, and research partners to explore possibilities within the coagulation cascade. Together, we're striving to get one step closer to tomorrow's discovery from the paths and partnerships we forge today.
Community commitment
Our desire to fulfill the needs of the hemophilia community goes beyond researching and developing new products. Pfizer Hemophilia is bringing meaningful change with programs, resources, and partnerships that provide information and support for patients and health care professionals.
National Hemophilia Foundation: searching for a cure
The National Hemophilia Foundation (NHF) is dedicated to finding better treatments and cures for bleeding disorders and preventing the complications of these disorders through education, advocacy, and research.
NACCHO: sharing best practices
The North American Camping Conference of Hemophilia Organizations (NACCHO) is the only global conference dedicated to sharing best practices for summer camps for children in the bleeding disorders community.
Coalition for Hemophilia B: bringing quality of life into focus
The Coalition for Hemophilia B was founded by the parents of a hemophilia B patient as a means of providing information about treatment options to patients and families. The coalition is committed to the support of scientific research and product development that will improve the quality of life for patients.
Hemophilia Federation of America (HFA): making treatment available
The Hemophilia Federation of America (HFA) assists patients and advocates for safe, affordable, and obtainable blood products and health coverage, as well as a better quality of life for all persons with bleeding disorders.
Discover the latest dosing option from Pfizer Hemophilia.
Demonstrated safety record
BeneFix has a demonstrated safety record with thousands of patients worldwide.
Real-life experiences
Real people. Real stories. Hear what others have to say about living with hemophilia B.
Wherever you are, find local Hemophilia Treatment Centers, and contact information for hemophilia specialists.
Discover the benefits of enhanced
room temperature storage convenience.
Find out how Pfizer can assist you with co-pay, deductible, and coinsurance costs.
Hemophilia Village Survey
Share your opinions now.
Mind Over Matters
Jump into the graphic saga of Bill and Grace.
H.I.S. Tips
Cool advice from the Hemophilia Information Service.
The Villager
Get the latest on
everything
hemophilia B.
Be prepared
Stay ahead of the curve with this list of downloadable tools.
What Is BeneFix?
BeneFix® Coagulation Factor IX (Recombinant) is an injectable medicine that is used to help control and prevent bleeding in people with hemophilia B. Hemophilia B is also called congenital factor IX deficiency or Christmas disease.
BeneFix is NOT used to treat hemophilia A.
Important Safety Information for BeneFix
BeneFix is contraindicated in patients who have manifested life-threatening, immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including hamster protein.
Call your health care provider right away if your bleeding is not controlled after using BeneFix.
Allergic reactions may occur with BeneFix. Call your health care provider or get emergency treatment right away if you have any of the following symptoms: wheezing, difficulty breathing, chest tightness, your lips and gums turning blue, fast heartbeat, facial swelling, faintness, rash or hives.
Your body can make antibodies, called "inhibitors," which may interfere with the effectiveness of BeneFix.
If you have risk factors for developing blood clots, such as a venous catheter through which BeneFix is given by continuous infusion, BeneFix may increase the risk of abnormal blood clots. The safety and efficacy of BeneFix administration by continuous infusion have not been established.
Some common side effects of BeneFix are nausea, injection site reaction, injection site pain, headache, dizziness and rash.
*BeneFix was approved February 11, 1997.
Please see full Prescribing Information for BeneFix.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
www.fda.gov/medwatch, or call 1-800-FDA-1088.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions about patient care must be made with a health care provider, considering the unique characteristics of the patient.
The product information provided in this site is intended for residents of the United States. The products discussed herein may have different product labeling in different countries.
BUS291810-01
